X

Xtant Medical Holdings Inc
AMEX:XTNT

Watchlist Manager
Xtant Medical Holdings Inc
AMEX:XTNT
Watchlist
Price: 0.81 USD 5.19% Market Closed
Market Cap: 113.4m USD

Wall Street
Price Targets

XTNT Price Targets Summary
Xtant Medical Holdings Inc

Wall Street analysts forecast XTNT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XTNT is 1.53 USD with a low forecast of 1.52 USD and a high forecast of 1.58 USD.

Lowest
Price Target
1.52 USD
87% Upside
Average
Price Target
1.53 USD
89% Upside
Highest
Price Target
1.58 USD
94% Upside
Xtant Medical Holdings Inc Competitors:
Price Targets
CERS
Cerus Corp
125% Upside
4549
Eiken Chemical Co Ltd
11% Downside
1501
Shanghai Kindly Medical Instruments Co Ltd
13% Upside
ALC
Alcon AG
31% Upside
LNTH
Lantheus Holdings Inc
25% Upside
RXST
Rxsight Inc
14% Downside
301101
Mingyue Optical Lens Co Ltd
54% Upside
NAN
Nanosonics Ltd
16% Upside

Revenue
Forecast

Revenue Estimate
Xtant Medical Holdings Inc

For the last 13 years the compound annual growth rate for Xtant Medical Holdings Inc's revenue is 11%. The projected CAGR for the next 3 years is 2%.

11%
Past Growth
2%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Xtant Medical Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat

Net Income
Forecast

Net Income Estimate
Xtant Medical Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-99%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XTNT's stock price target?
Price Target
1.53 USD

According to Wall Street analysts, the average 1-year price target for XTNT is 1.53 USD with a low forecast of 1.52 USD and a high forecast of 1.58 USD.

What is Xtant Medical Holdings Inc's Revenue forecast?
Projected CAGR
2%

For the last 13 years the compound annual growth rate for Xtant Medical Holdings Inc's revenue is 11%. The projected CAGR for the next 3 years is 2%.

Back to Top